Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
OPTIMICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients who Achieve PCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
NCT Number:
NCT05812807
Phase:
III
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Breast
Study Objectives:
To evaluate whether observation results in a non-inferior RFS compared to adjuvant
pembrolizumab in early-stage TNBC patients who achieve a pCR after neoadjuvant
chemotherapy with pembrolizumab
Study Documents
(MUSC NetID required for document access)